摘要
目的研究山茱萸(Cornus officinalis Sieb.et Zucc.)成熟果实的化学成分及其对缺氧缺糖(oxygen-glucose deprivation,OGD)损伤PC12细胞的保护作用。方法采用大孔吸附树脂、硅胶、ODS、Sephadex LH-20柱色谱和制备HPLC等技术进行分离和纯化,结合理化性质及MS、NMR等波谱方法鉴定化合物的结构,并采用MTT法测定其对OGD损伤的PC12细胞的保护作用。结果从山茱萸成熟果实水提取物中分离得到8个化合物,分别为6'-O-乙酰基-7β-O-乙基莫诺苷(1),金圣草黄素(2),木犀草素(3),5-羟甲基糠醛(4),丁香酸(5),对羟基苯甲酸(6),咖啡酸甲酯(7)和没食子酸乙酯(8)。结论化合物1为新化合物,化合物2,3,5,7为首次从山茱萸植物中分离得到;化合物4在1.0μmol·L^(-1)的浓度下,对OGD/R损伤的PC12细胞具有一定的保护作用。
OBJECTIVE To study the chemical constituents from the ripe fruits of Comus officinalis Sieb. et Zucc. , and evaluate their protection on PC12 ceils exposed to oxygen and glucose deprivation. METHODS The compounds were isolated through various chromatographic methods including macroporous adsorption resin, silica gel, ODS, Sephadex LH -20 column chromatography, and preparative HPLC, and their structures were determined through spectroscopic analysis, including 1D and 2D NMR and MS da- ta. RESULTS Eight compounds were isolated from the water extract of the ripe fruits of Comus officinalis Sieb. et Zucc. , and their structures were elucidated as 6'-O-acetyl-7β-O-ethyl morroniside ( 1 ), chrysoderol ( 2), luteolin ( 3 ), 5-hydroxymethylfurfural (4), sy- ringate(5) ,p-hydroxybenzoic acid(6) ,caffeic acid methyl ester(7), ethyl gallate(8). CONCLUSION Compound 1 is a new iridoid glucoside, and compounds 2, 3, 5, 7 are obtained from Comus officinalis for the first time. The MTF results show that compound 4 moderately increases the viability of OGD/R treated PC12 cells at the concentration of 1.0 μmol · L-1.
作者
乔灏祎
叶贤胜
赫军
王晓雪
张佳琳
庞晓斌
张维库
续洁琨
QIAO Hao-yi YE Xian-sheng HE Jun WANG Xlao-xu ZHANG Jxa-lin PANG Xiao-bin ZHANG Wei- ku XU Jie-kun(School of Life Sciences, Beijing University of Chinese Medicine, Beijing 100029, China lr~titute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing 100029, China School of Chinese Materia Medica, Beijing U- niversity of Chinese Medicine, Beijing 100029, China Department of Pharmacy, China-Japan Friendship Hospital, Beijing 100029, China Pharmaceutical Institute, Henan University, Kaifeng 475004, China Beijing Key Lab for Immune-Mediated Inflammatory Diseases, Beijing 100029, China)
出处
《中国药学杂志》
CAS
CSCD
北大核心
2017年第14期1212-1216,共5页
Chinese Pharmaceutical Journal
基金
国家自然科学基金资助项目(81473119
81473590)
北京市科委十病十药研究专项资助(Z171100001717009)